Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
33.36
-0.47 (-1.39%)
At close: Nov 13, 2026, 4:00 PM EST
33.36
0.00 (0.00%)
Pre-market: Nov 16, 2026, 5:40 AM EST
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $2.34 billion as of November 13, 2026. It is the 5,950th most valuable company in the world and the 1,655th biggest in the United States. Its market cap has increased by 39.69% in one year.
Market Cap
2.34B
Enterprise Value
2.02B
1-Year Change
39.69%
Global Rank
Country Rank
#1,655 United States
Category
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $2.34B, an increase of 267.78%. That is a compound annual growth rate of 25.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 2.34B | 29.92% |
| Dec 31, 2025 | 1.80B | 73.39% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arcus Biosciences | 2.51B |
| NewAmsterdam Pharma Company | 2.42B |
| Beam Therapeutics | 2.28B |
| Celldex Therapeutics | 2.26B |
| Palvella Therapeutics | 2.23B |
| Immunome | 2.22B |
| Lakefront Biotherapeutics NV | 2.14B |
| Aurinia Pharmaceuticals | 2.11B |